Back to text»You are here: Home » News » Novartis Divest Its Blood Transfusion Diagnostics Unit to Grifols for $1.675bn » Comments List

Novartis Divest Its Blood Transfusion Diagnostics Unit to Grifols for $1.675bnComments List

Favorable comment		0%	0
Average		0%	0
Poor		0%	0